Skip to main content
. 2022 Feb 23;16(6):952–963. doi: 10.5009/gnl210391

Table 3.

Summary Sensitivities, Specificities, Diagnostic Odds Ratio, Positive Likelihood Ratio, Negative Likelihood Ratio and AUC of FIB-4 Index and NFS According to Region or Body Mass Index for Prediction of Advanced Fibrosis

Variable Cutoff No. of samples
(No. of patients)
Summary statistics (95% CI)
Sensitivity Specificity DOR LR+ LR– AUC
Region
FIB-4 (F3) Asia 12 (3,388) 0.48 (0.36–0.60) 0.86 (0.80–0.91) 6.09 (4.44–8.36) 3.63 (2.77–4.75) 0.59 (0.49–0.72) 0.74 (0.71–0.77)
Europe 6 (1,978) 0.61 (0.43–0.76) 0.91 (0.83–0.95) 16.37 (7.93–33.74) 6.95 (3.91–12.32) 0.42 (0.27–0.64) 0.80 (0.78–0.82)
America 8 (4,155) 0.51 (0.37–0.65) 0.85 (0.71–0.93) 6.23 (2.51–15.47) 3.52 (1.72–7.22) 0.56 (0.42–0.75) 0.73 (0.68–0.78)
NFS (F3) Asia 12 (3,407) 0.38 (0.24–0.54) 0.90 (0.83–0.95) 6.22 (4.52–8.57) 4.20 (3.07–5.76) 0.67 (0.55–0.82) 0.70 (0.65–0.74)
Europe 7 (2,098) 0.55 (0.39–0.71) 0.94 (0.85–0.98) 21.94 (10.03–47.94) 10.23 (4.43–23.64) 0.46 (0.33–0.65) 0.83 (0.80–0.86)
America 8 (4,447) 0.50 (0.33–0.68) 0.78 (0.64–0.87) 3.70 (1.77–7.74) 2.33 (1.44–3.77) 0.62 (0.45–0.88) 0.72 (0.69–0.76)
Body mass index
FIB-4 (F3) <30 kg/m2 12 (3,870) 0.50 (0.38–0.61) 0.88 (0.82–0.92) 7.67 (5.46–10.78) 4.33 (3.21–5.85) 0.56 (0.46–0.68) 0.75 (0.71–0.82)
30 to <35 kg/m2 10 (1,331) 0.51 (0.38–0.64) 0.88 (0.78–0.93) 7.92 (3.73–16.81) 4.33 (2.39–7.85) 0.54 (0.41–0.71) 0.74 (0.72–0.76)
≥35 kg/m2 4 (675) 0.60 (0.48–0.71) 0.82 (0.69–0.90) 7.31 (5.29–10.12) 3.49 (2.26–5.40) 0.47 (0.39–0.57) 0.77 (0.74–0.80)
NFS (F3) <30 kg/m2 12 (3,889) 0.35 (0.23–0.50) 0.93 (0.88–0.96) 8.17 (5.54–12.05) 5.60 (3.82–8.21) 0.68 (0.57–0.82) 0.71 (0.67–0.75)
30 to <35 kg/m2 9 (4,583) 0.51 (0.35–0.66) 0.84 (0.75–0.91) 5.96 (2.77–12.85) 3.41 (1.98–5.86) 0.57 (0.41–0.78) 0.73 (0.70–0.67)
≥35 kg/m2 6 (2,205) 0.55 (0.33–0.76) 0.83 (0.61–0.94) 6.37 (3.82–10.63) 3.38 (1.81–6.32) 0.53 (0.37–0.75) 0.80 (0.74–0.85)

AUC, area under curve; FIB-4, fibrosis-4; NFS, nonalcoholic fatty liver disease (NAFLD) fibrosis score; CI, confidence interval; DOR, diagnostic odds ratio; LR+, positive likelihood ratio; LR–, negative likelihood ratio.